跳至主要内容
临床试验/ACTRN12607000390482
ACTRN12607000390482招募中1 期

Performance of the miniaturo™-I system for treatment of Urinary Urge Incontinence to improve the number of leaking episodes

American Medical Systems Australia0 个研究点目标入组 30 人开始时间: 2007年7月24日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 ot stated(—)
性别
Female

入选标准

  • 1.Patient who failed conservative treatments (i.e. lifestyle modification-fluid consumption, behavioral modification, and pharmacological therapy) for at least 6 months.2.Overactive detrusor demonstrated on cystometry during the last 6 months or patients who are regarded as sensory urgency3.Urinary Urge Incontinence greater then 5 episodes per day4.Urinary frequency greater than 10 times/day and 3 times/night5.Patients with competent sphincter mechanism6.Patients with normally functioning upper urinary tract 7.Passing miniaturo-I Test System session

排除标准

  • Exclusion criteria1.Previous participation in another study with any investigational drug or device within the past 3 months2.Any active implant (cardiac or other)3.Previous urinary incontinence surgery or implantation of artificial graft material within the last 6 months4.Any spinal or genitourinary surgery within the last 6 months5.Previous abdominoperineal resection of the rectum or radical hysterectomy within the last 6 months 6.Anatomical defects that preclude use of the device7.PVR> 100 ml8.VLPP > 100 cmH2O on urodynamic testing9.Primary pelvic pain syndrome10.Obvious clinically demonstrated genuine stress incontinence11.Presence of cystocele, enterocele or rectocele of grade 3 or 4 (if applicable)12.Any neurological disease or disorder13.Current urinary tract infection or chronic inflammation, presence of urinary stone and/or urinary tract malignancy (i.e. tumor, urethritis, vesicourethral reflux, etc.)14.Pelvic radiotherapy and chemotherapy15.Morbid obesity 16.Severe uncontrolled diabetes17.Any severe heart disease18.Patients requiring frequent magnetic resonance imaging (MRI) exams19.Current pregnancy or attempting to get pregnant (female patient)20.Patient with uncontrolled bleeding coagulopathy.

研究者

发起方
American Medical Systems Australia

相似试验